org placeholder image

Evangeline Eddy

Assoc Director, Toxicology at Imbrium Therapeutics

  • LinkedIn

Email Email: e****@imbriumthera.com

phone noPhone Number: (***)-***-****

map
IMBRIUM THERAPEUTICS

IMBRIUM THERAPEUTICS

  • description Description
    Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursuing ...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 1 Million to 5 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Imbrium Therapeutics Org Chart and Mapping

Employees

Jaya Nair

Senior Analytical Scientist

Deb Burko

Associate Director, Scientific Communications and Verification

Ellie H

Head of Biometrics

Greg Sparta

Executive Director Regulatory Affairs

Diane Kocot

Regulatory Affairs Specialist

D Boykin

Executive Administrative Assistant

Frequently Asked Questions Regarding Evangeline Eddy

Answer: Evangeline Eddy works for Imbrium Therapeutics as Assoc Director, Toxicology

Answer: Evangeline Eddy’s role in Imbrium Therapeutics is Assoc Director, Toxicology

Answer: Evangeline Eddy's email address is e***@gmail.com

Answer: Evangeline Eddy's business email address is e****@imbriumthera.com

Answer: Evangeline Eddy’s direct phone number is (***)-***-****

Answer: Evangeline Eddy works in the industry of: Biotechnology

Answer: Evangeline Eddy works Imbrium Therapeutics located at 201 Tresser BLVD, Stamford, Connecticut, 06901, United States

Answer: Imbrium Therapeutics's Assoc Director, Toxicology is Evangeline Eddy

Answer: Evangeline Eddy contact details:

  • Phone number  :  (***)-***-****
  • Email  :  e****@imbriumthera.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access